Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug News and Perspectives

Fisher A, Barak D Progress and perspectives in new muscarinic agonists. Drug News and Perspective 7[8) 453-464, 1994... [Pg.636]

Drug News and Perspective 7 403-443, 1993 Willner P Animal models as simulations of depression. Trends Pharmacol Sci 12 131-136, 1991... [Pg.769]

Drug news and perspective. Cephalon licenses modafinil from Laboratoire L. Lafon. R and D briefs. Drug News Perspect, 1993 6(2) 113. [Pg.445]

SaUwanchik, D. R., and Saliwanchik, R. Effective documentation of research results, Drug News and Perspectives 5(5), 306-313 (1992). [Pg.137]

Kohn, J. (1991b) Pseudo-poly(ainino acids). Drug News and Perspectives, 4(5), 289-294. [Pg.277]

Palmer, A.M. and Stephenson, E.A. (2005) CNS drug discovery challenges and solutions. Drug News S, Perspectives,... [Pg.142]

HariKrishna, D. Raghu Ram Rao, A. and Krishna, D.R. (2003) Selective activation of anthracycline prodrugs for use in conjunction with ADEPT. Drug News el Perspectives, 16, 309-318. [Pg.570]

Banta, D. (2(X)0). Increase in global access to essential drugs sought (medical news and perspectives). Journal of the American Medical Association. 283,... [Pg.71]

Drug News Perspectives. Drug News Perspectives [91] is a drug newsmagazine for scientists and managers in pharmaceutical research and development. Sections include research and... [Pg.779]

Brown, R. E. (2003). Involvement of hypocretins/orexins in sleep disorders and narcolepsy. Drug News Perspect. 16, 75-9. [Pg.48]

Dutta AS, Garner A. The pharmaceutical industry and research in 2020 and beyond. Drug News Perspect 2003 16 637-48. [Pg.86]

Koles L, Furst S, Hies P P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. Drug News Perspect 2005 18 85. [PMID 15883618]... [Pg.466]

Coop, A. and Rice, K.C. Role of delta opioid receptors in biological processes, Drugs News Perspect. 2000, 13, 481-487. [Pg.464]

Collister K. A. and Albensi B. C. (2005). Potential therapeutic targets in the NF-icB pathway for Alzheimer s disease. Drug News Perspect. 18 623-629. [Pg.192]

Moreira P. L., Smith M. A., Zhu X. W., Flonda K., Lee FI. G., Aliev G., and Perry G. (2005b). Oxidative damage and Alzheimer s disease Are antioxidant therapies useful Drug News Perspect. 18 13-19. [Pg.198]

Elrod JW, Lefer DJ. The effects of statins on endothelium, inflammation and cardioprotection. Drug News Perspect. 2005 18 229-236. [Pg.364]

Willis GL. The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson s disease. Drug News Perspect. 2005 18 437-444. [Pg.618]

R.E. Armer and RM. Cowley, Trends in medicinal chemistry 2004, Drug News Perspect., 18, 142-148 (2005). [Pg.62]

Ueda, H., and Rashid, M. H. (2003). Molecular mechanism of neuropathic pain. Drug News. Perspect. 16, 605-613. [Pg.190]

Baslow MH. 2008. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target. Drug news perspect 21 251-257. [Pg.76]

Lundstedt, T. A QSAR Strategy for Screening of Drugs and Predicting Their Clinical Activity. Drug News Perspect., 1991, 4(8), 468-474. [Pg.219]

Graul Al (2009) Promoting, improving and accelerating the drug development and approval processes. Drug News Perspect 22(l) 30-38... [Pg.796]

Horvath EM, Szabo C. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer an update. Drug News Perspect. 2007 20 171-181. [Pg.184]

Wang X, Eeuerstein GZ (2000) Role of immune and inflammatory mediators in CNS injury. Drug News Perspect 13 133-140. [Pg.678]

For a review of both human and nonhuman cysteinyl leukotriene receptors, see J. S. Sawyer and D. L. Saussy Jr, Drug News Perspect., 6,139-149 (1993). [Pg.252]

Jakel, H., Fruchart-Najib, J., Fruchart, J. C. Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosis. Drug News Perspect. 2006, 19, 91-97. [Pg.105]

Waeber, C., Blondeau, N., Salomone, S. Vascular sphingosine-l-phosphate SlPl and S1P3 receptors. Drug News Perspect 17 (2004) 365-382. [Pg.296]

Sphker, B. Phases of clinical trials and phases of drug development, Drug News Perspectives 9(10), 601-606 (1996). [Pg.72]

See other pages where Drug News and Perspectives is mentioned: [Pg.154]    [Pg.288]    [Pg.417]    [Pg.156]    [Pg.156]    [Pg.154]    [Pg.288]    [Pg.417]    [Pg.156]    [Pg.156]    [Pg.581]    [Pg.215]    [Pg.779]    [Pg.779]    [Pg.534]    [Pg.426]    [Pg.551]    [Pg.545]    [Pg.288]    [Pg.218]    [Pg.182]    [Pg.78]    [Pg.255]    [Pg.66]    [Pg.451]    [Pg.265]    [Pg.173]   
See also in sourсe #XX -- [ Pg.154 , Pg.288 ]



SEARCH



News

© 2024 chempedia.info